Posted by
Paul Fletcher
1 Comments
Tentative FDA approval for generics means the drug is scientifically ready - but legal, manufacturing, or economic barriers often block its market launch. Here's why so many generics never reach patients.
read morePosted by
Paul Fletcher
0 Comments
The FDA doesn't stop monitoring generic drugs after approval. Using real-time data, inspections, and patient reports, it tracks safety issues long after these affordable medications hit the market. Here's how it works.
read morePosted by
Paul Fletcher
0 Comments
Checkpoint inhibitors and CAR-T cell therapy are transforming cancer treatment by harnessing the immune system. Learn how they work, who benefits most, their side effects, and why access remains unequal.
read more